Tag: diabetes

1. Patients who used continuous glucose monitoring (CGM) showed significantly reduced glycated hemoglobin (HbA1C) levels compared to those who used standard blood glucose monitoring (BGM) after 26 weeks. 2. On average, patients in the CGM group spent more time in the target glucose range (70-180 mg/dL) compared to those in...

1. Patients who underwent Roux-en-Y gastric (RYGB) surgery had higher rates of microalbuminuria remission when compared to those who received only medical treatment at 24 months post-intervention. 2. Patients who underwent RYGB surgery also showed improvements in metabolic control outcomes (HbA1C, LDL-C, triglycerides, and change in total body weight) when...

1. Insulin costs steadily increased from 2006-2017. However, the out-of-pocket costs to privately insured patients remained consistent, in-part due to decreased cost-sharing. 2. Privately insured consumers with health savings accounts (HSAs) paid significantly more in out of pocket costs in comparison to those with health reimbursement arrangements (HRAs) or no-account...

1. Adolescent obesity was significantly associated with cancer incidence in young and mid adulthood, and could be an important intervention target for early cancer prevention Evidence Rating: 2 (Good) Despite obesity being an established causal factor for at least 12 types of cancer, the relationship between youth obesity and cancers have...

1. Children of mothers with diabetes are more likely to develop cardiovascular disease. Evidence Rating Level: 2 (Good) The prevalence of cardiovascular disease (CVD) in children and young adults is increasing. Growing evidence suggests that maternal health during or before pregnancy may impact the development of CVD among offspring. Maternal diabetes is...

1. Early combination therapy with vildagliptin and metformin is associated with improved glycemic durability in the setting of newly diagnosed type 2 diabetes. Evidence Rating Level: 1 (Excellent) Early glycemic control in type 2 diabetes is associated with glycemic durability and a reduced risk of developing related complications. The early introduction...

1. In this large, longitudinal cohort study from the United States, patients with poor health status were more likely to continue insulin use compared with healthier patients. Evidence Rating Level: 2 (Good) Study Rundown: Type 2 Diabetes Mellitus (DM2) is one of the most common chronic illnesses in the world. Glycemic...

The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomised trial 1. Selective serotonin reuptake inhibitors (SSRIs) are not associated with significant short-term reductions in depressive symptoms in the primary care setting, but reduce short-term anxiety and improve...

1. No significant difference in severe UTIs was observed between patients starting SGLT-2 inhibitors for type 2 diabetes, compared to DPP-4 inhibitors or GLP-1 agonists. Evidence Rating Level: 2 (Good) Study Rundown: The sodium glucose cotransporter-2 (SGLT-2) inhibitors are a newer class of diabetic medications that act by inhibiting glucose reabsorption in...

1. No significant difference in severe UTIs was observed between patients starting SGLT-2 inhibitors for type 2 diabetes, compared to DPP-4 inhibitors or GLP-1 agonists. Evidence Rating Level: 2 (Good) Study Rundown: The sodium glucose cotransporter-2 (SGLT-2) inhibitors are a newer class of diabetic medications that act by inhibiting glucose reabsorption...